Effect of Azelaic Acid on Psoriasis Progression Investigated Based on Phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B (AKT) Signaling Pathway

References

• Korman NJ. Management of psoriasis as a systemic disease: what is the evidence? Br J Dermatol. 2020;182(4):840–848. doi:10.1111/bjd.18245
   PubMed Web of Science ®Google Scholar
• Sato Y, Ogawa E, Okuyama R. Role of innate immune cells in psoriasis. Int J Mol Sci. 2020;21(18):6604. doi:10.3390/ijms21186604
   PubMed Web of Science ®Google Scholar
• Palijan T, Kovačević D, Vlastelica M, Dadić-Hero E, Sarilar M. Quality of life of persons suffering from schizophrenia, psoriasis and physical disabilities. Psychiatr Danub. 2017;29(1):60–65. doi:10.24869/psyd.2017.60
   PubMed Web of Science ®Google Scholar
• Xie Y, Shi X, Sheng K, et al. PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review). Mol Med Rep. 2019;19(2):783–791. doi:10.3892/mmr.2018.9713
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhang X. The role of PI3K/AKT/FOXO signaling in psoriasis. Arch Dermatol Res. 2019;311(2):83–91. doi:10.1007/s00403-018-1879-8
   PubMed Web of Science ®Google Scholar
• Lv H, Liu X, Chen W, et al. Yangxue jiedu fang ameliorates psoriasis by regulating vascular regression via Survivin/PI3K/Akt pathway. J Immunol Res. 2021;2021:4678087. doi:10.1155/2021/4678087
   PubMed Web of Science ®Google Scholar
• Searle T, Ali FR, Al-Niaimi F. The versatility of azelaic acid in dermatology. J Dermatol Treat. 2022;33(2):722–732. doi:10.1080/09546634.2020.1800579
   PubMed Web of Science ®Google Scholar
• Dayal S, Sahu P, Dua R. Combination of glycolic acid peel and topical 20% azelaic acid cream in melasma patients: efficacy and improvement in quality of life. J Cosmet Dermatol. 2017;16(1):35–42. doi:10.1111/jocd.12260
   PubMed Web of Science ®Google Scholar
• Pazoki-Toroudi H, Nilforoushzadeh MA, Ajami M, et al. Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris. Cutan Ocul Toxicol. 2011;30(4):286–291. doi:10.3109/15569527.2011.581257
   PubMed Web of Science ®Google Scholar
• Iraji F, Faghihi G, Siadat AH, et al. Efficacy of 15% azelaic acid in psoriasis vulgaris: a randomized, controlled clinical trial. J Drugs Dermatol. 2010;9(8):964–968.
   PubMed Web of Science ®Google Scholar
• MacArthur Clark JA, Sun D. Guidelines for the ethical review of laboratory animal welfare People’s Republic of China National Standard GB/T 35892–2018 [Issued 6 February 2018 Effective from 1 September 2018]. Anim models exp med. 2020;3(1):103–113. doi:10.1002/ame2.12111
   PubMedGoogle Scholar
• de Alcantara CC, Reiche EMV, Simão ANC. Cytokines in psoriasis. Adv Clin Chem. 2021;100:171–204.
   PubMed Web of Science ®Google Scholar
• Tokuyama M, Mabuchi T. New treatment addressing the pathogenesis of psoriasis. Int J Mol Sci. 2020;21(20):7488. doi:10.3390/ijms21207488
   PubMed Web of Science ®Google Scholar
• Vičić M, Kaštelan M, Brajac I, Sotošek V, Massari LP. Current concepts of psoriasis immunopathogenesis. Int J Mol Sci. 2021;22(21):11574. doi:10.3390/ijms222111574
   PubMed Web of Science ®Google Scholar
• Koycheva IK, Mihaylova LV, Todorova MN. Leucosceptoside a from Devil’s Claw modulates psoriasis-like inflammation via suppression of the PI3K/AKT signaling pathway in keratinocytes. Molecules. 2021;26(22):7014. doi:10.3390/molecules26227014
   PubMed Web of Science ®Google Scholar
• Wang H, Ran LW, Hui K, Wang XY, Zheng Y. Expressions of survivin, PI3K and AKT in keratinocytes in skin lesions and their pathogenic role in psoriasis vulgaris. Nan fang yi ke da xue xue bao. 2017;37(11):1512–1516.
   PubMedGoogle Scholar
• Gao J, Guo J, Nong Y, et al. 18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice. BMC Pharmacol Toxicol. 2020;21(1):41. doi:10.1186/s40360-020-00419-0
   PubMed Web of Science ®Google Scholar
• Chamcheu JC, Esnault S, Adhami VM. Fisetin, a 3,7,3’,4’-Tetrahydroxyflavone inhibits the PI3K/Akt/mTOR and MAPK pathways and ameliorates psoriasis pathology in 2D and 3D organotypic human inflammatory skin models. Cells. 2019;8(9):1089. doi:10.3390/cells8091089
   PubMed Web of Science ®Google Scholar
• Blauvelt A, Chiricozzi A. The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis. Clin Rev Allergy Immunol. 2018;55(3):379–390. doi:10.1007/s12016-018-8702-3
   PubMed Web of Science ®Google Scholar
• Mercurio L, Albanesi C, Madonna S. Recent updates on the involvement of PI3K/AKT/mTOR molecular cascade in the pathogenesis of hyperproliferative skin disorders. Front med. 2021;8:665647. doi:10.3389/fmed.2021.665647
   Web of Science ®Google Scholar
• Chamcheu JC, Adhami VM, Esnault S, et al. Dual inhibition of PI3K/Akt and mTOR by the dietary antioxidant, delphinidin, ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like disease in mice. Antioxid Redox Signal. 2017;26(2):49–69. doi:10.1089/ars.2016.6769
   PubMed Web of Science ®Google Scholar
• Roller A, Perino A, Dapavo P, et al. Blockade of phosphatidylinositol 3-kinase PI3Kδ or PI3Kγ reduces IL-17 and ameliorates imiquimod-induced psoriasis-like dermatitis. J Immunol. 2012;189(9):4612–4620. doi:10.4049/jimmunol.1103173
   PubMed Web of Science ®Google Scholar
• Desai SJ, Prickril B, Rasooly A. Mechanisms of phytonutrient modulation of Cyclooxygenase-2 (COX-2) and inflammation related to cancer. Nutr Cancer. 2018;70(3):350–375. doi:10.1080/01635581.2018.1446091
   PubMed Web of Science ®Google Scholar
• Zhang X, Qu P, Zhao H, Zhao T, Cao N. COX‑2 promotes epithelial‑mesenchymal transition and migration in osteosarcoma MG‑63 cells via PI3K/AKT/NF‑κB signaling. Mol Med Rep. 2019;20(4):3811–3819. doi:10.3892/mmr.2019.10598
   PubMed Web of Science ®Google Scholar
• Sharma P, Caldwell TS, Rivera MN, Gullapalli RR. Cadmium exposure activates Akt/ERK signaling and pro-inflammatory COX-2 expression in human gallbladder epithelial cells via a ROS dependent mechanism. Toxicol in Vitro. 2020;67:104912. doi:10.1016/j.tiv.2020.104912
   PubMed Web of Science ®Google Scholar
• Dinicola S, Fabrizi G, Masiello MG, et al. Inositol induces mesenchymal-epithelial reversion in breast cancer cells through cytoskeleton rearrangement. Exp Cell Res. 2016;345(1):37–50. doi:10.1016/j.yexcr.2016.05.007
   PubMed Web of Science ®Google Scholar
• Wójcik P, Biernacki M, Wroński A, Łuczaj W. Altered lipid metabolism in blood mononuclear cells of psoriatic patients indicates differential changes in psoriasis vulgaris and psoriatic arthritis. Int J Mol Sci. 2019;20(17):4249. doi:10.3390/ijms20174249
   PubMed Web of Science ®Google Scholar
• Karar J, Maity A. PI3K/AKT/mTOR pathway in angiogenesis. Front Mol Neurosci. 2011;4:51. doi:10.3389/fnmol.2011.00051
   PubMed Web of Science ®Google Scholar
• Yang C, Liu X, Zhao K, et al. miRNA-21 promotes osteogenesis via the PTEN/PI3K/Akt/HIF-1α pathway and enhances bone regeneration in critical size defects. Stem Cell Res Ther. 2019;10(1):65. doi:10.1186/s13287-019-1168-2
   PubMedGoogle Scholar
• Ahluwalia A, Tarnawski AS. Critical role of hypoxia sensor--HIF-1α in VEGF gene activation. Implications for angiogenesis and tissue injury healing. Curr Med Chem. 2012;19(1):90–97. doi:10.2174/092986712803413944
   PubMed Web of Science ®Google Scholar
• Zhu WJ, Li P, Wang L, Xu YC. Hypoxia-inducible factor-1: a potential pharmacological target to manage psoriasis. Int Immunopharmacol. 2020;86:106689. doi:10.1016/j.intimp.2020.106689
   PubMed Web of Science ®Google Scholar
• Pulkkinen HH, Kiema M, Lappalainen JP, et al. BMP6/TAZ-Hippo signaling modulates angiogenesis and endothelial cell response to VEGF. Angiogenesis. 2021;24(1):129–144. doi:10.1007/s10456-020-09748-4
   PubMed Web of Science ®Google Scholar
• Zhi S, Li J, Kong X, Xie X, Zhang Q, Fang G. Insulin-like growth factor 2 mRNA binding protein 2 regulates proliferation, migration, and angiogenesis of keratinocytes by modulating heparanase stability. Bioengineered. 2021;12(2):11267–11276. doi:10.1080/21655979.2021.2002495
   PubMed Web of Science ®Google Scholar
• Zhang C, Xu Q, Tan X, et al. Astilbin decreases proliferation and improves differentiation in HaCaT keratinocytes. Biomed Pharmacother. 2017;93:713–720. doi:10.1016/j.biopha.2017.05.127
   PubMed Web of Science ®Google Scholar
• Suhng E, Kim BH, Choi YW, Choi HY, Cho H, Byun JY. Increased expression of IL-33 in rosacea skin and UVB-irradiated and LL-37-treated HaCaT cells. Exp Dermatol. 2018;27(9):1023–1029. doi:10.1111/exd.13702
   PubMed Web of Science ®Google Scholar
• Kwon YW, Kwon KS, Moon HE, et al. Insulin-like growth factor-II regulates the expression of vascular endothelial growth factor by the human keratinocyte cell line HaCaT. J Invest Dermatol. 2004;123(1):152–158. doi:10.1111/j.0022-202X.2004.22735.x
   PubMed Web of Science ®Google Scholar
• Cucci LM, Satriano C, Marzo T, La Mendola D. Angiogenin and copper crossing in wound healing. Int J Mol Sci. 2021;22(19):10704. doi:10.3390/ijms221910704
   PubMed Web of Science ®Google Scholar
• Tian X, Zhang N, Yan C, et al. CREG promotes vasculogenesis by activation of VEGF/PI3K/Akt pathway. Front Biosci. 2014;19(8):1215–1226. doi:10.2741/4277
   Web of Science ®Google Scholar
• Liu XB, Jiang J, Gui C, Hu XY, Xiang MX, Wang JA. Angiopoietin-1 protects mesenchymal stem cells against serum deprivation and hypoxia-induced apoptosis through the PI3K/Akt pathway. Acta Pharmacol Sin. 2008;29(7):815–822. doi:10.1111/j.1745-7254.2008.00811.x
   PubMed Web of Science ®Google Scholar
• Searle T, Ali FR, Al-Niaimi F. Perioral dermatitis: diagnosis, proposed etiologies, and management. J Cosmet Dermatol. 2021;20(12):3839–3848.
   PubMed Web of Science ®Google Scholar
• Dall’Oglio F, Tedeschi A, Lacarrubba F, et al. A novel azelaic acid formulation for the topical treatment of inflammatory rosacea: a multicentre, prospective clinical trial. J Cosmet Dermatol. 2021;20 Suppl 1(Suppl1):28–31. doi:10.1111/jocd.14098
   PubMed Web of Science ®Google Scholar
• Liu H, Yu H, Xia J, et al. Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne. Cochrane Database Syst Rev. 2020;5(5):Cd011368. doi:10.1002/14651858.CD011368.pub2
   PubMed Web of Science ®Google Scholar
• Coda AB, Hata T, Miller J, et al. Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel. J Am Acad Dermatol. 2013;69(4):570–577. doi:10.1016/j.jaad.2013.05.019
   PubMed Web of Science ®Google Scholar